Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 428 results for "genentech rank"

NewLink-Roche Ink Deal for Oncology Candidate Development

NewLink Genetics Corporation ( NLNK ) announced that it has signed an exclusive worldwide license agreement with Genentech, a subsidiary of Roche ( RHHBY ), for the development of its oncology candidate NLG919. NLG919, an IDO inhibitor, is in phase ... Yahoo! Finance, 1 month ago
Investing.com

Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog

Roche's ( RHHBY ) subsidiary Genentech and its partner Exelixis, Inc. ( EXEL ) announced that Roche has submitted a new drug application (NDA) in the U.S. for the use of cobimetinib plus Zelboraf in treatment-naive patients with unresectable locally ...
 Zacks.com1 day ago Roche says head of Genentech research unit to retire  Investing.com3 days ago

Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants 12/10/2014

December 9, 2014 By Riley McDermid , BioSpace.com Breaking News Sr. Editor Major drug maker Genentech ( RHHBY ) is coming under fire Tuesday, after a report in the New York Times found that doctors who prescribed the company's pricey cancer ...
 ClinicSpace1 week ago

FDA approves bevacizumab plus chemo for platinum-resistant, recurrent ovarian cancer

The US Food and Drug Administration has approved bevacizumab solution for intravenous infusion (Avastin, Genentech, Inc.) in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for the treatment of patients with ...
 Ecancer Medicalscience1 month ago Yet another indication for Roche's blockbuster Avastin from FDA16-11-2014  Pharma Letter1 month ago
Seeking Alpha

NewLink Genetics: Examining Likelihood Of Success In The IMPRESS Trial

Summary Many investors and commentators have failed to appreciate the risk/reward associated with NewLink's (NLNK) IMPRESS phase 3 trial for surgically resected pancreatic cancer. Analysis presented herein suggests the IMPRESS trial is likely to ...
 Seeking Alpha1 day ago

Does Gilead's new oncology hire signal a new push?

The biopharma industry's headlong rush into cancer drug research has created a fierce competition for top talent in the field, as underscored by Gilead's ( $GILD ) decision to raid the senior ranks of Genentech for an R&D leader who's being charged ...
 FierceBiotech2 days ago Does Gilead's oncology hire signal a new R&D push?  FierceBiotech2 days ago

Pharmaceuticals and Drug Manufacturing Industry Analytics 2014-2021: Extensive Financial Benchmarks, Metrics and Revenue Forecasts - Market to reach $227.6 billion by 2021

Research and Markets (http://www.researchandmarkets.com/research/ggnrfj/pharmaceuticals) has announced the addition of Plunkett Research Ltd's new report "Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial ...
 Individual.com3 days ago United States Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry Analytics 2014-2021 - Market to to Reach $315.6 Billion by 2021  Individual.com3 days ago Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400  MarketResearch.com2 days ago Research and Markets: Pharmaceuticals and Drug Manufacturing Industry Analytics 2014-2021: Extensive Financial Benchmarks, Metrics and Revenue Forecasts - Market to reach $227.6 billion by 2021  TMC Net3 days ago
[x]  

The Courage of Jill Costello

After a promising junior season as a coxswain at Cal, she learned she was in the late stages of cancer. The next year was her best Next spring the NCAA women's crew season will begin again. On lakes and rivers across the country, fleets of ...
 SI.com5 days ago
SAS

SAS #2 on Healthiest Companies List

Considering work is the second most common source of stress (after money), and that 42 percent of respondents in one survey reported a stressful work environment as the reason they jumped ship,it's about time more offices promoted a healthy ...
 SAS6 days ago

Seven pioneers who are re-imagining medtech

As medtech continues to shape-shift, check out these seven pioneers - just some of the early-stage companies devoted to re-imagining the healthcare sector. AllazoHealth AllazoHealth is a predictive analytics company that solves the problem of ...
 Medical Plastics News1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less